+AGIL Barcelona: Integrated Care for Community-Dwelling Frail Older Adults

计划入组 396 人 · 首次发布于 2025 年 2 月 20 日

INTER-PATHOLOGIST READER STUDY

计划入组 500 人 · 首次发布于 2024 年 2 月 7 日

Optimizing Medical "Teaming" on Resident Based Teams

计划入组 33 人 · 首次发布于 2022 年 1 月 28 日

BP-Inter-014

Interferon alpha-2a biosimilar (Biosidus)

inter alpha inhibitor proteins (sepsis/brain injury/necrotizing enterocolitis)

Surgical Review Corporation

United States

Institutional Review Board

United States

Inter-American Development Bank

Trinidad and Tobago

USPTO Proposes Major Restrictions on Inter Partes Review Patent Challenges

Patent Disputes Highlight Innovation Challenges in Photodynamic Therapy and Genomic Sequencing Technologies

Gilead Sciences Settles Patent Dispute with Laurus Labs Over HIV Drug Tenofovir